Related Experiment Video
Updated: Jan 31, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Public-private partnerships are critical for rapid response to infectious disease threats
Jennifer Rakeman-Cagno1, Larry Kelmar2, Michael Loeffelholz3
1Cepheid, Medical and Scientific Affairs, Public Health Programs, Sunnyvale, CA, United States.
Abstract:
Public-private partnerships focused on infectious disease diagnostics have been increasing since the COVID-19 pandemic. These partnerships have resulted in new test development, increased testing capacity and services, technology development, and processes to enable faster collaborative response in the context of an outbreak. This paper explores the importance of public-private partnerships in response to infectious disease public health threats. Collaboration between federal partners and diagnostic test manufacturers has been critical to the COVID-19, mpox, and other responses in the United States, and these partnerships will be critical to future responses. Public-private partnerships pull together the pieces needed to rapidly develop and scale diagnostics necessary for responding to emerging infectious diseases. Developing partnerships during "peace time" further enables rapid action when outbreaks occur.
Related Concept Videos
Stereotype Threat and Self-fulfilling Prophecies
Threats to Biodiversity
Critical Region, Critical Values and Significance Level
In hypothesis testing, a sample statistic is converted to a test statistic using z, t, or chi-square distribution. A critical region is an area under the curve in probability distributions demarcated by the critical value. When the test statistic falls in this region, it suggests that the null hypothesis must be rejected. As this region contains all those values of the...
Critical Values
Responses to Drought and Flooding
Critical Thinking I

